Viewing Study NCT01853306


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2026-03-01 @ 11:28 AM
Study NCT ID: NCT01853306
Status: COMPLETED
Last Update Posted: 2017-11-21
First Post: 2013-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Oncology View
None BRCA Mutated View
None High Grade Serous Ovarian Cancer View
None BRCA Mutated Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High grade serous ovarian cancer View
None BRCA mutated breast cancer View
None BRCA mutated View
None Oncology View